公式タイトルと情報はIP Exchange PlusとPremiumのユーザーのみが利用可能です。
特許 係属中 Amplification or over-expression of the ERBB2 gene occurs in approximately 15-30% of breast cancers.[1][5] It is strongly associated with increased disease recurrence and a poor prognosis.[6] Over-expression is also known to occur in ovarian, stomach, and aggressive forms of uterine cancer, such as uterine serous endometrial carcinoma.
追加情報の詳細を見るにはIP Exchange PlusまたはIP Exchange Premiumアカウントにアップグレードする必要があります
